cambridge's bluebird bio licenses delivery tech to novartis, gsk.: "evidence for decreased calcitonin gene-related peptide (cgrp) receptors and compromised responsiveness to cgrp of fetoplacental vessels in preeclamptic pregnancies.".
.
international....: "arise: a phase 3 randomized trial of erenumab for episodic migraine."